Extended-Release Medications for Obesity Treatment
follow us on twitter: @GoAfricaNetwork JAMA March 24/31, 2015 Naltrexone Extended-Release Plus Bupropion Extended-Release for Treatment of Obesity In September 2014, a proprietary formulation of naltrexone extended-release (ER) plus bupropion-ER (brand name Contrave) was approved by the US Food and Drug Administration (FDA),1 becoming the fourth medication approved for long-term weight management in patients with […]
Extended-Release Medications for Obesity Treatment Read More »